Prosight Management, LP

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 1617201 DALLAS, TX

Position in CRBP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,545,844

+$979,126 QoQ

Shares Held

697,108

+1.9% QoQ

Ownership

3.76%

of shares outstanding

% of Portfolio

1.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Prosight Management, LP holds $368,598,367 across 29 Biotechnology names. CRBP ranks #14 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NKTR	Nektar Therapeutics	735,000	$52,883,250
2	JANX	Janux Therapeutics, Inc.	3,550,000	$49,345,000
3	LKFT	Lakefront Biotherapeutics NV	1,550,000	$46,500,000
4	STTK	Shattuck Labs, Inc.	5,004,439	$32,178,542
5	KURA	Kura Oncology, Inc.	3,356,700	$27,289,971
6	ALNY	Alnylam Pharmaceuticals, Inc.	76,000	$25,146,120
7	MGTX	MeiraGTx Holdings plc	2,629,971	$22,775,548
8	SNDX	Syndax Pharmaceuticals Inc	770,000	$17,987,200

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,545,844	697,108	+1.9%	Shares	Sole	2026-05-15
2025-12-31	$5,566,718	683,872	+99.1%	Shares	Sole	2026-02-13
2025-09-30	$4,344,010	343,400	-40.8%	Shares	Sole	2025-11-14
2025-06-30	$4,001,261	579,893	+0.8%	Shares	Sole	2025-08-14
2025-03-31	$3,053,972	575,136	+113.0%	Shares	Sole	2025-05-15
2024-12-31	$3,186,000	270,000	+107.7%	Shares	Sole	2025-02-14
2024-09-30	$2,681,900	130,000	+29.2%	Shares	Sole	2024-11-14
2024-03-31	$3,948,211	100,617	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.